SRPT•benzinga•
RBC Capital Maintains Outperform on Sarepta Therapeutics, Lowers Price Target to $161
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 27, 2025 by benzinga